Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes

Diabetic Medicine

Volumn 25, Issue 10, 2008, Pages 1157-1163

  Inoue, Kazuo ^a   Matsumoto, Masatoshi ^b   Akimoto, Kimihiko ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c Yuport Medical Check up Center   (Japan)

Author keywords

Blood glucose; Cohort study; Diabetes mellitus; Glycated haemoglobin; Japan

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HAZARD RATIO; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RETROSPECTIVE STUDY; RISK FACTOR; TIME SERIES ANALYSIS;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HEALTH SURVEYS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REFERENCE STANDARDS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 53349166779     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02572.x     Document Type: Article

References (36)

1. IDF. Diabetes Atlas, 2nd ed. Brussels : International Diabetes Federation, 2003.
2. Dinneen SF, Maldonado D, Leibson CL, Klee GG, Li H, Melton LJ et al. Effects of changing diagnostic criteria on the risk of developing diabetes. Diabetes Care 1998 21 : 1408 1413.
3. Chou P, Li CL, Wu GS, Tsai ST. Progression to Type 2 diabetes among high-risk groups in Kin-Chen, Kinmen: exploring the natural history of Type 2 diabetes. Diabetes Care 1998 21 : 1183 1187.
4. Edelstein SL, Knowler WC, Bain RP, Andres R, Barrett Conner EL, Dowse GK et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 1997 46 : 701 710.
5. Dotevall A, Johansson S, Wilhelmsen L, Rosengren A. Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women: a prospective 18-year follow-up of the BEDA study. Diabet Med 2004 21 : 615 622.
6. Wannamethee SG, Shaper AG, Lennon L, Whincup PH. Hepatic enzymes, the metabolic syndrome, and the risk of Type 2 diabetes in older men. Diabetes Care 2005 28 : 2913 2918.
7. Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of Type 2 diabetes. Diabetes 2002 51 : 455 461.
8. Barr RG, Nathan DM, Meigs JB, Singer DE. Tests of glycemia for the diagnosis of Type 2 diabetes mellitus. Ann Intern Med 2002 137 : 263 272.
9. American Diabetes Association. Standards of medical care in diabetes 2006. Diabetes Care 2006 29 : S4 S42.
10. The Expert Committee on the Diagnosis Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003 26 : 3160 3167.
11. 1c, glycosylated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 1995 18 : 440 447.
12. 1c measurements do not improve the detection of Type 2 diabetes in a randomly selected population. Diabetes Care 2001 24 : 2017 2018.
13. 1c measurement improves the detection of Type 2 diabetes in high-risk individuals with non-diagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP). Diabetes Care 2001 24 : 465 471.
14. Davidson MB, Schriger DL, Peters AL, Lorber B. Relationship between fasting plasma glucose and glycosylated haemoglobin: potential for false-positive diagnoses of Type 2 diabetes using new diagnostic criteria. J Am Med Assoc 1999 281 : 1203 1210.
15. 1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects. Diabetes Care 1998 21 : 1221 1225.
16. 1c predicts the progression to diabetes in Chinese subjects. Diabetes Care 2000 23 : 1770 1773.
17. 1c; a long-term follow-up study of screened non-diabetic subjects. J Japan Diab Soc 2001 44 : 745 750.
18. Inoue K, Matsumoto M, Kobayashi K. The combination of fasting plasma glucose and glycosylated haemoglobin predicts Type 2 diabetes in Japanese workers. Diab Res Clin Pract. 2007 77 : 451 458.
19. Japan Diabetes Society. Practice Guideline for Diabetes. Tokyo : Japan Diabetes Society, 2002.
20. International Federation of Clinical Chemistry Laboratory Medicine. Relation between IFCC numbers and the respective national DCMs. Available at http://www.ifcchba1c.net/IFCC_08.asp Last accessed 2 April 2008.
21. 1c levels in non-diabetic residents of three distinct areas of Japan. Diab Res Clin Pract 2001 53 : 91 97.
22. Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M et al. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. Diabetes Res Clin Pract 2002 55 : 65 85.
23. 1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 2004 50 : 166 174.
24. 1c. I: comparison of Japan Diabetes Society-assigned values to those obtained by the Japanese and USA domestic standardization programmes and by the International Federation of Clinical Chemistry reference laboratories. Ann Clin Biochem 2005 42 : 41 46.
25. 1c in the Diabetes Control and Complications Trial. Diabetes Care 2002 25 : 275 278.
26. Expert Committee on the Diagnosis Classification of Diabetes Mellitus. Report. Diabetes Care 1997 20 : 1183 1197.
27. Japan Diabetes Society Committee on the Classification Diagnostic Criteria of Diabetes Mellitus. Report (in Japanese). J Japan Diab Soc 1999 42 : 385 404.
28. 1c methods on GMS clinical indicators. Diabet Med 2008 25 : 97 100.
29. 1c methods and the GMS contract. Int J Clin Pract 2008 62 : 202 205.
30. Avignon A, Radauceanu A, Monnier L. Non-fasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in Type 2 diabetes. Diabetes Care 1997 20 : 1822 1826.
31. Dinneen S, Gerich J, Rizza R. Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med 1992 327 : 707 713.
32. Bogardus C, Lillioja S, Mott D, Reaven GR, Kashiwagi A, Foley JE. Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians. J Clin Invest 1984 73 : 800 805.
33. Rothman DL, Magnusson I, Katz LD, Shulman RG, Shulman GI. Quantification of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science 1991 254 : 573 576.
34. Yki-Jarvinen H. Fat in the liver and insulin resistance. Ann Med 2005 37 : 347 356.
35. Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E et al. Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 2001 86 : 3257 3265.
36. Bugianesi E, Zannoni C, Vanni E, Marzocchi R, Marchesini G. Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship? Dig Liver Dis 2004 36 : 165 173.